The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials

MLA

Valter Torri, et al. The Prognostic Impact of Primary Tumour Location in Patients with Stage II and Stage III Colon Cancer Receiving Adjuvant Therapy. A GISCAD Analysis from Three Large Randomised Trials. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cf318817cc954d753edd960780c594c8&authtype=sso&custid=ns315887.

APA

Valter Torri, R. Labianca, Vittorina Zagonel, Alberto Sobrero, Davide Poli, A. Zaniboni, Maria Banzi, M. Di Bartolomeo, Mario Scartozzi, Gerardo Rosati, Stefano Cascinu, Sara Lonardi, & Nicoletta Pella. (2019). The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.

Chicago

Valter Torri, R. Labianca, Vittorina Zagonel, Alberto Sobrero, Davide Poli, A. Zaniboni, Maria Banzi, et al. 2019. “The Prognostic Impact of Primary Tumour Location in Patients with Stage II and Stage III Colon Cancer Receiving Adjuvant Therapy. A GISCAD Analysis from Three Large Randomised Trials,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cf318817cc954d753edd960780c594c8&authtype=sso&custid=ns315887.